Cellular characteristics of peripheral blood lymphocytes and tumour-infiltrating lymphocytes in patients with gynaecological tumours

Cancer Immunology Immunotherapy

Volumn 44, Issue 2, 1997, Pages 88-96

  Schöndorf, Thomas ^a   Engel, Heike ^a,b   Lindemann, Carsten ^b   Kolhagen, Hannelore ^a   Von Rücker, Alexander A ^b   Mallmann, Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

cellular characterization; gynaecological cancer; interphase cytogenetics; TIL

Indexed keywords

ARTICLE; BLOOD CELL; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE; NATURAL KILLER CELL; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BREAST NEOPLASMS; CD4-CD8 RATIO; CELL DIVISION; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 7; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; OVARIAN NEOPLASMS; UTERINE NEOPLASMS;

EID: 0030953029     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050360     Document Type: Article

References (58)

1. Anichini A, Mortarini R, Alberti S, Mantovani A, Parmiani G (1993) T-cell-receptor engagement and tumor ICAM-1 up-regulation are required to by-pass low susceptibility of melanoma cells to autologous CTL-mediated lysis. Int J Cancer 53:994
2. Apirantitou-Drogari M, Paganin C, Bernasconi S, Losa G, Maneo A, Colombo N, Mantovani A, Allavena P (1992) In search of specific cytotoxic T lymphocytes infiltating or accompanying human ovarina carcinoma. Cancer Immunol Immunother 35:289
3. Arienti F, Belli F, Rivoltini L, Gambacorti-Passerini C, Furlan L, Mascheroni L, Prada A, Rizzi M, Marchesi E, Vaglini M, Parmiani G, Cascinelli N (1993) Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL2. Cancer Immunol Immunother 36:315
4. Bateman WJ, Donnellan I, Fraser IA, Wong LS, Morris AG (1995) Lymphocytes infiltrating colorectal cancer have low proliferative capacity but can secrete normal levels of interferon-γ. Cancer Immunol Immunother 41:61
5. Baxevanis CN, Dedoussis GVZ, Papadopoulos NG, Missitzis I, Stathopoulos GP, Papamichail M (1994) Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Cancer 74:1275
6. Bendall LJ, Kortlepel K, Gottlieb DJ (1995) GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1. Leukemia 9:677
7. Bernhard H, Karbach J, Wölfel T, Busch P, Störkel S, Stöckle M, Wölfel C, Seliger B, Huber C, Meyer zum Büschenfelde KH, Knuth A (1994) Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones. Int J Cancer 59:837
8. Bukowski RM, Sharfman W, Murthy S, Rayman P, Tubbs R, Alexander J, Budd GT, Sergi JS, Bauer L, Gibson V, Stanley J, Boyett J, Pontes E, Finke J (1991) Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin-2 in human metastatic renal cell carcinoma. Cancer Res 51:4199
9. Cajulis RS, Kotliar S, Haines GK, Frias-Hidvegi D, O'Gorman M (1994) Comparative study of interphase cytogenetics, flow cytometric analysis, and nuclear grade of fine-needle aspirates of breast carcinoma. Diag Cytopathol 11:151
10. Chin Y, Janseens J, Vandepitte J, Vandenbrande J, Opdebeek L, Raus J (1992) Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 12:1463
11. + T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion. Cancer Immunol Immunother 40:1
12. Dal Cin P, Aly SA, Delabie J, Ceuppens JL, van Gool S, van Damme B, Baert L, van Poppel H, Berghe H van den (1992) Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue. Proc Natl Acad Sci USA 89:9744
13. Donnerstag B, Schröder W, Hoos P, Oltrogge JB, Trager L, Bender HG (1994) Interactions between tumor cells and tumor infiltrating lymphocytes in human ovarian carcinoma. Clin Exp Obstet Gynecol 21:153
14. Finke JH, Rayman P, Hart L, Alexander JP, Edinger MG, Tubbs RR, Klein E, Tuason L, Bukowski RM (1994) Characterization of tumor-infiltrating lymphocytes subsets from human cell carcinoma: specific reactivity defined by cytotoxicity, interferon-γ secretion and proliferation. J Immunother Emphasis Tumor Immunol 15:91
15. Fisher RI, Coltman CA, Doroshow JH, Rayner AA, Hawkins MJ, Mier JW, Wiernik P, McMannis JD, Weiss GD, Margolin KA, Gemlo BT, Hoth DF, Parkinson DR, Paietta E (1988) Metastatic renal cell cancer treated with interleukin-2 and lymphokine-activated killer cells: a phase II trial. Ann Intern Med 108:518
16. Freedman RS, Ioannides CG, Mathioudakis G, Platsoucas CD (1992) Novel immunologic strategies in ovarian carcinoma. Am J Obstet Gynecol 167:1470
17. Goedegebuure PS, Zuber M, Leonard-Vidal DL, Burger UL, Cusack Jr. JC, Chang MP, Douville LM, Eberlein TJ (1994) Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacy. Surg Oncol 3:79
18. + tumor-infiltrating lymphocytes in human solid tumors. Immunol Res 14:119
19. Hammond-McKibben DM, Seth A, Nagarkatti PS, Nagarkatti M (1995) Characterization of factors regulating successful immunotherapy using a tumor-specific cytotoxic T lymphocyte clone: role of interleukin-2, cycling pattern of lytic activity and adhesion molecules. Int J Cancer 60:828
20. Horvath J, Sinkovics JG (1994) Adoptive immunotherapy with activated peripheral blood lymphocytes. Leukemia 8 [Suppl 1]:S121
21. Ikarashi H, Fujita K, Takakuwa K, Kodama S, Tokunaga A, Takahashi T, Tanaka K (1994) Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Cancer Res 54:190
22. Jung T, Schauer U, Heusser C, Neumann C, Rieger C (1993) Detection of intracellular cytokines by flow cytometry. J Immunol Methods 159:197
23. Karimine N, Nanbara S, Arinaga S, Asoh T, Ueo H, Akiyoshi T (1994) Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients. J Surg Oncol 55:179
24. Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58:317
25. Kim HJ, Heo DS, Suh CI, Kim HT, Bang YJ, Kim NK (1995) In vitro generation of immune effector cells from tumor-associated lymphocytes of human gastric cancer. Anticancer Res 15:1247
26. Kooi S, Freedman RS, Rodriguez-Villanueva J, Platsoucas CD (1993) Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune response and inhibition of antigen-independent cytokine production by ovarian tumor cells. Lymphokine Cytokine Res 12:429
27. Kurt RA, Park JA, Panelli MC, Schluter SF, Marchalonis JJ, Carolus B, Akporiaye ET (1995) T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities. J Immunol 154:3969
28. Lanier LL, O'Fallon S, Somoza C, Philips JH, Linsley PS, Okumura K, Ito D, Azuma M (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for Tcell proliferation, cytokine production, and generation of CTL. J Immunol 154:97
29. + T helper subsets in human melanoma. Surgery 117:365
30. Liu SQ, Shiba R, Kim BS, Saijo K, Ohno T (1994) Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells. Cancer Immunol Immunother 39:279
31. Liu SQ, Saijo K, Todoroki T, Ohno T (1994) Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Nature Med 1:267
32. Lotzova E (1988) Ovarian tumor-infiltrating lymphocytes: phenotype and antitumor activity. Nat Immun Cell Growth Regul 7:226
33. Lucci JAI, Manetta A, Capuccini F, Ininns EK, Dett CA, DiSaia P, Yamamaoto RS, Berman ML, Soopikian J, Granger GA (1992) Immunotherapy of ovarian cancer II. In vitro generation and chracterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients. Gynecol Oncol 45:129
34. + cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles. Int J Cancer 57:56
35. Maley DT, Simon P (1990) Cytotoxicity assays using target cell pre-labelled with the fluorescent marker europium. J Immunol Methods 134:61
36. Mallmann P (1993) Autologous tumor-cell vaccination and lymphokine-activated tumor-infiltrating lymphocytes (LAK-TIL). Hybridoma 12:559
37. Mallmann P, Eis-Hübinger AM, Krebs D (1992) Lymphokine-activated tumor-infiltrating lymphocytes and autologous tumor vaccine in breast and ovarian cancer. Onkologie 15:490
38. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145
39. O'Garra A, Murphy K (1996) Role of cytokines in development of Th1 and Th2 cells. In: Romagnani S (ed) Th1 and Th2 cells in health and disease. Chemical Immunology Vol. 63, Basel, p 1
40. Persons DL, Hartmann LC, Herath JF, Keeney GL, Jenkins RB (1994) Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102:775
41. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wie JP, White DE (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319:1676
42. Roussel E, Gingras MC, Grimm EA, Roth JA (1995) High expression of adhesion molecules/activation markers with little interleukin-2, interferon-γ, and tumor necrosis factor β gene activation in fresh tumor-infiltrating lymphocytes from lung adenocarcinoma. Cancer Immunol Immunother 41:1
43. Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP (1996) Predomonance of a type 2 intratumoral immune response in fresh tumor-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105:344
44. Salmeron MA, Morita T, Seki H, Platsoucas CD, Itoh K (1992) Lymphokine production by human melanoma tumor-infiltrating lymphocytes. Cancer Immunol Immunother 35:211
45. Schoof DD, Gramolini BA, Duvidson DL, Massaro AF, Wilson RE, Eberlein TJ (1988) Adoptive immunotherapy of human cancer using low-dose recombinant interleukin-2 and lymphokine-activated killer cells. Cancer Res 48:5007
46. Schwartzentruber DJ, Solomon D, Rosenberg SA, Topalian SL (1992) Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother 12:1
47. Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, el-Gamil M, Rosenberg SA, Yannelli JR (1995) Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogenic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition. J Immunol 154:762
48. Sussman JJ, Shu S, Sondak VK, Chang AE (1994) Acitivation of T lymphocytes for the adoptive immunotherapy of cancer. Ann Surg Oncol 1:296
49. Tani M, Tanimura H, Yamaue H, Mizobata S, Iwahashi M, Tsunoda T, Noguchi K, Tamai M, Hotta T, Terasawa H, Arii K (1995) Generation of CD4+ cytotoxic T lymphocytes stimulated by immobilized anti-CD3 monoclonal antibody and interleukin-2 in cancer patients. Int J Cancer 60:802
50. Topalian SL, Solomon D, Avis FP (1988) Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study. J Clin Oncol 6:839
51. Van den Berg-Bakker CA, Hagemeijer A, Franken-Postma EM, Smit VT, Kuppen PJ, Ravenswaay Claasen HH van, Cornelisse CJ, Schrier PI (1993) Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: growth features and cytogenesis. Int J Cancer 53:613
52. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL (1992) Expression of mRNA for cytokines in tumor-infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51:573
53. Wang Q, Radovan C, Tubbs R, Olnecki T, Klein E, Kudoh S, Finke J, Bukowski RM (1995) Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Int J Cancer 61:780
54. Whiteside TL, Parmiani G (1994) Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use. Cancer Immunol Immunother 39:15
55. Wimmenauer S, Keller H, Rahner S, Kirste G, Von Bergwelt M, Meyer A, Von Kleist S, Farthmann EH (1994) Phenotypical and functional characteristics of tumor-infiltrating lymphocytes from colon carcinomas stimulated with rIL-2 and rIL-4 in vitro: comparison with lymphocytes of the normal colon mucosa and the peripheral blood. Anticancer Res 14:963
56. Yanelli JR, Hyatt C, McConnell S, Hines K, Jacknin L, Parker L, Sanders M, Rosenberg SA (1996) Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience. Int J Cancer 65:413
57. Yoshino I, Yano T, Murata M, Miyamoto M, Ishida T, Sugimachi K, Kimura G, Nomoto K (1993) Phenotypes of lymphocytes infiltrating non-small lung cancer tissues and its variation with histological types of cancer. Lung Cancer 10:13
58. Zocchi MR, Poggi A, Crosti F, Tongiani S, Rugarti C (1992) Signalling in human tumor infiltrating lymphocytes: the CD28 molecule is functional and is physically associated with CD45RO molecule. Eur J Cancer 28:749